10-fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a parisian check-up centre

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 3, 2013, Pages 562-568

  Nicolas chanoine, Marie Hélène ^a,b,c   Gruson, Coraline ^c   Bialek Davenet, Suzanne ^a,b,c   Bertrand, Xavier ^d   Thomas Jean, Frédérique ^e   Bert, Frédéric ^a   Moyat, Mati ^a   Meiller, Elodie ^a   Marcon, Estelle ^a   Danchin, Nicolas ^e   Noussair, Latifa ^a   Moreau, Richard ^c   Leflon Guibout, Véronique ^a  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e Centre IPC   (France)

Author keywords

Clones ST131; CTX M; E. coli dominant population; SHV 12; ST10; ST69

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM CARRIER; BACTERIUM DETECTION; BACTERIUM ISOLATION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FRANCE; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PHYLOGENY; QUESTIONNAIRE;

ADULT; AGED; BETA-LACTAMASES; CARRIER STATE; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PARIS; PHYLOGENY; PREVALENCE; QUESTIONNAIRES;

EID: 84873580588     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks429     Document Type: Article

References (41)

1. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6.
2. Jarlier V, Nicolas MH, Fournier G et al. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
3. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
4. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
5. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
6. Pallecchi L, Bartoloni A, Fiorelli C et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51: 2720-5.
7. Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamaseproducing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769-75.
8. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD et al. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-9.
9. Leflon-Guibout V, Blanco J, Amaqdouf K et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008; 46: 3900-5.
10. Laupland KB, Church DL, Vidakovich J et al. Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 2008; 57: 441-8.
11. Nicolas-Chanoine MH, Jarlier V, Robert J et al. Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a casecontrol-control study. PLoS ONE 2012; 7: e30498.
12. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-42.
13. Cattoir V, Poirel L, Rotimi V et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007; 60: 394-7.
14. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
15. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
16. Feil EJ. Small change: keeping pace with microevolution. Nat Rev Microbiol 2004; 2: 483-95.
17. Ben Sallem R, Ben Slama K, Estepa V et al. Prevalence and characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 1511-6.
18. Geser N, Stephan R, Korczak BM et al. Molecular identification of blaESBL genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2011; 74: 446-9.
19. Janvier F, Merens A, Delaune D et al. Fecal carriage of third-generation cephalosporins-resistant Enterobacteriaceae in asymptomatic young adults: evolution between 1999 and 2009. Pathol Biol 2011; 59: 97-101.
20. Li B, Sun JY, Liu QZ et al. High prevalence of CTX-M β-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 2011; 43: 170-4.
21. Luvsansharav UO, Hirai I, Niki M et al. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011; 17: 722-5.
22. Luvsansharav UO, Hirai I, Niki M et al. Analysis of risk factors for a high prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand. J Med Microbiol 2011; 60: 619-24.
23. Abdul Rahman EM, El-Sherif RH. High rates of intestinal colonization with extended-spectrum lactamase-producing Enterobacteriaceae among healthy individuals. J Invest Med 2011; 59: 1284-6.
24. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007; 28: 1114-6.
25. Smith DL, Dushoff J, Perencevich EN et al. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004; 101: 3709-14.
26. Girlich D, Poirel L, Carattoli A et al. Extended-spectrum β-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France. Appl Environ Microbiol 2007; 73: 4681-5.
27. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2010; 17: 873-80.
28. Meunier D, Jouy E, Lazizzera C et al. CTX-M-1 and CTX-M-15 type β-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France. Int J Antimicrob Agents 2006; 28: 402-7.
29. Fam N, Leflon-Guibout V, Fouad S et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 2011; 17: 67-73.
30. Gibreel TM, Dodgson AR, Cheesbrough J et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J Antimicrob Chemother 2012; 67: 346-56.
31. Oteo J, Diestra K, Juan C et al. Extended-spectrum β-lactamaseproducing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int J Antimicrob Agents 2009; 34: 173-6.
32. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
33. Dias RC, Marangoni DV, Smith SP et al. Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the state of Rio de Janeiro, Brazil. Microb Drug Resist 2009; 15: 303-8.
34. Manges AR, Perdreau-Remington F, Solberg OD et al. Multidrugresistant Escherichia coli clonal groups causing community-acquired bloodstream infections. J Infect Dis 2006; 53: 25-9.
35. Blanco J, Mora A, Mamani R et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011; 66: 2011-21.
36. Corvec S, Cremet L, Leprince C et al. Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic β-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis 2010; 67: 277-81.
37. Mushtaq S, Irfan S, Sarma JB et al. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 2011; 66: 2002-5.
38. Gijon D, Curiao T, Baquero F et al. Fecal carriage of carbapenemase producing Enterobacteriaceae: a hidden reservoir in hospitalized and non-hospitalized patients. J Clin Microbiol 2012: 50: 1558-63.
39. CTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J Antimicrob Chemother 2011; 66: 1263-8.
40. Mora A, Blanco M, Lopez C et al. Emergence of clonal groups O1:HNMD-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 2011; 37: 16-21.
41. Cortes P, Blanc V, Mora A et al. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 2010; 76: 2799-805.